An autologous tumor vaccine prepared from tumor tissue of patients, designed to stimulate a specific immune response against tumor antigens.

A service collaborating with qualified hospitals to prepare and administer autologous immune cell therapies, including T cells, NK cells, or DC cells, for cancer treatment.